Protective effect of periplaneta americana extract on intestinal mucosal barrier function in patients with sepsis  by Zhang, Hongwei et al.
CLINICAL STUDY
JTCM |www. journaltcm. com February 15, 2013 |volume 33 | Issue 1 |
Online Submissions:http://www.journaltcm.com J Tradit Chin Med 2013 February 15; 33(1): 70-73
info@journaltcm.com ISSN 0255-2922
© 2013 JTCM. All rights reserved.
Protective effect of periplaneta americana extract on intestinal mu-
cosal barrier function in patients with sepsis
Hongwei Zhang, LiyouWei, Zhenyu Zhang, Shuzheng Liu, Gang Zhao, Jing Zhang, Yanling Hu
aa
Hongwei Zhang, Gang Zhao, The Department ofIntensive
Care Unit,The second Hospital of Tangshan, Tangshan
063000, China
Liyou Wei, The Department of Orthopaedics, The second
Hospital of Tangshan, Tangshan 063000, China
Zhenyu Zhang, Shuzheng Liu, Jing Zhang, Yanling Hu,
The Department of Intensive Care Unit,People's Hospital of
Tangshan, Tangshan 063000, China
Correspondence to: Prof. LiyouWei, Department of Ortho-
paedics, The second Hospital of Tangshan, Tangshan
063000, China. weiliyou888@163.com
Telephone: +86-13091057129
Accepted: December 12, 2012
Abstract
OBJECTIVE: To investigate the effect of the peripla-
neta americana extract on the intestinal mucosal
barrier and prognostic implications in patients with
sepsis.
METHODS: Sixty and six patients with sepsis were
assigned randomly to treatment group (32 cases)
and control group (32 cases). The extractfrom peri-
planeta americana plus conventional medication
for sepsis was administered to the treatment
group, while the control group only received con-
ventional treatment. The gastrointestinal function
scores and acute physiology and chronic health
evaluation II (APACHEⅡ) scores of all subjects were
documented at baseline, at days 1, 3 and 7 after
treatment respectively and their blood endotoxin
was tested at the same time points as well. The inci-
dence of death was recorded for both groups
throughout the trial.
RESULTS: At days 3 and 7 after treatment, gastroin-
testinal function score, APACHE II, and endotoxin
level in treatment group wasbetter than that in con-
trol group and the difference between them was
significant (both P<0.05). Although the incidence
of death in treatment group was less than that in
control group, the difference between the two
groups was not significant (P> 0.05).
CONCLUSION: The extract of periplaneta ameri-
cana had protective effect on intestinal mucosal
barrier and could improve the condition and prog-
nosis in patients with sepsis.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Sepsis is one of the serious complications of trauma,
burns, infections and major surgical operation in criti-
cally ill patients. It can induce multiple organ dysfunc-
tion syndrome (MODS) and acute MODS is a major
cause of death in Intensive Care Unit (ICU).1,2 Its inci-
dence is increasing year by year and average mortality
rate was 28.6% and increased with age from 10% in
children to 38.4% in those over 85 years.3Gastrointesti-
nal tract is the central organ of the stress response, due
to bacterium, endotoxin translocation and intestinal
immune function decline caused by intestinal barrier
dysfunction, which is an important cause of MODS.4,5
In the early stage, administration of medications to pro-
tect intestinal mucosal barrier in patients with sepsis
has great clinical significance. The extract of periplane-
ta americana had a protective effect on gastric mucosa
by increasing its blood flow, improving microcircula-
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tion, and promoting gastric mucosal repair.6
Between January 2009 and December 2010, the treat-
ment of sepsis with periplaneta americana extract was
investigated in our hospitals. The study was approved
by our hospital's Ethic Committeeand was conducted
in accordance with the ethical standards laid down in
the Declaration of Helsinki. Subjects all signed an in-
formed consent form prior to participating in the study.
METHODS
Subjects
A total of 64 patients, 42 males and 22 females, with
sepsis admitted to our hospital's ICU, were aged be-
tween 19 and 71. Thirty-four patients with injuries in-
cluding 14 multiple injuries combined with shock, 6
open fractures, 8 chest or abdomen open injuries, 6
burns; 15 infection patients including 10 severe pneu-
monias, 3 empyemata, 2 liver abscesses; 15 postopera-
tivepatients. They were randomly assigned to treat-
ment group and control group, 32 subjects for each
group.
Inclusion and exclusion criteria
The diagnostic criteria of sepsis were recommended by
the International Sepsis Conference in December
2001.7 Patients meeting the criteria were included with-
out history of peptic ulcer or other gastrointestinal un-
derlying diseases. Those with following conditions
were excluded: intestinal paralysis due to anesthesia, hy-
pokalemia, machinery and other causes, malignant he-
matologic diseases, rheumatic diseases, and acquired
immune deficiency syndrome.
Interventions
The extract from periplaneta americana plus conven-
tional medications for sepsis was administered to the
treatment group, while the control group only received
conventional treatment. The conventional treatment
included blood and fluids transfusion, protective me-
chanical ventilation, analgesic, sedative, anti-inflamma-
tory, and anti-infective medications, nutritional sup-
port, water and electrolyte balance maintaining, and so
forth. The extract of periplaneta americana (kangfuxin
solution, Hunan Nanke Lun Pharmaceutical Co., Ltd.)
was administered by stomach tube, 10 mL/time, tid,
starting from the day when diagnosis wasconfirmed
and the treatment ofthe extractlasted for 7 days.
Outcome measurement
At the beginning of treatment and at days 1, 3, 7 af-
ter treatment, gastrointestinal function score and
acute physiology and chronic health evaluation II
(APACHE II) were recorded respectively and blood
endotoxin was tested at the same time points. Inci-
dence of death was record as well. Normal gastroin-
testinal function was scored 0, abdominal distension
and decreased bowel sounds scored 1, high degree of
abdominal bloating and intestinal sound almost ab-
sentscored 2, paralytic ileusand/or stress ulcer bleed-
ing scored 3.8 Plasma endotoxin was tested with Lim-
ulus test. Reagent was produced by Shanghai Yihua
Chinese Medical Technology Co., Ltd., Shanghai,
PRC. The equipment was UV-visible spectrophotom-
eter manufactured by PERKIN-ELMER Corpora-
tion, Norwalk, USA.
Data analysis
Data was analyzed with SPSS17.0. Chi-square and t
test etc were performed for the analysis. The descrip-
tive data was expressed with mean±standard deviation
( xˉ ± s ). P<0.05 was the significant level.
RESULTS
General information of the two groups
The gender ratios, ageand primary disease of two
groupswere insignificantly different (P>0.05). 5 death
in treatment group, and 7 in control group. The inci-
dence of death (15.63%) in treatment group was lower
than that (21.88% ) in control group. The difference
was not significant (P>0.05). See Table 1.
Comparisons of gastrointestinal function
Before treatment, the gastrointestinal function scores
of the two groups were insignificantly different (P>
0.05). Three and seven days after treatment, Treatment
groups' gastrointestinal function score was compared
with that of control group with Mann-Whitney test.
The difference was significant (P<0.05). See Table 2.
Comparisons of endotoxin
Before treatment, the blood endotoxin (EU/mL) in the
Notes: Patients in control group received conventional treatment; the extract from periplanetaamericana plus conventional medications for
sepsis was administered to the treatment group.
Table 1 The basic features in two groups
Group
Control
Treatment
χ2/t, P value
Gender (case)
Male/female
22/10
20/12
χ2=0.277, P=0.599
Age ( xˉ ± s , year)
51±13
52±15
t=0.715, P=0.368
Primary disease (case)
Injuries/infections/
postoperative
18/6/8
16/9/7
χ2=0.784, P=0.676
Cases（days1/3/7）
7（2/3/2）
5（3/1/1）
-
Death
Incidence (%)
21.88
15.63
χ2=0.410, P=0.522
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two groups were insignificantly different (P>0.05).On
days 3, 7 after treatment, the difference of blood endo-
toxin between the T group and C group were statistical-
ly significant by t test (P<0.05, Figure 1).
Comparisons of APACHE II
Before treatment, the APACHE II scores in the two
groups were insignificantly different (P>0.05). On
days 3, 7 after treatment, the difference of APACHE
II score between the T group and C group were statisti-
cally significant by t test (P<0.05, Figure 2).
DISCUSSION
Sepsis, defined as an infection accompanied by in-
flammation, is a serious condition caused by systemic
inflammatory response. A rapid progression from sep-
sis to severe sepsis to septic shock frequently occurs
driven by inflammatory and anti-inflammatory re-
sponses to a pathogen, which makes the condition re-
quire immediate intervention.9 Intestinal tract is the
body's largest lymphoid organ. It has proved that the
dysfunction of gutbarrier plays an important role in
the development of sepsis.10,11 In patients with sepsis-
the damage to their gastrointestinal barrier, and intes-
tinal bacteria and toxins invasion of circulation sys-
tem result in gut-derived infection. If the exacerbated
inflammatory response is out of control, MODS
eventually ensues and it significantly impacts on the
patients' prognosis.
The periplaneta americana extract is made with etha-
nol from American periplaneta dry worm. It contains
peptides, polyols, epidermal growth factor, sticky sug-
ar acid, amino acids, and other active substances.
Studies showed that periplaneta americana extract
could promote gastric mucosal synthesis of PGE2, in-
crease vascular tone, reduce vascular permeability, re-
duce local congestion, protect the lysosomal mem-
brane, avoid the cathepsin hydrolase release caused
by lysosomal rupture, reduce the tissue decomposi-
tion, inhibit the release of inflammatory mediators
and suppress neutrophils, monocytes and macro-
phages.12 The protective effect of periplaneta ameri-
cana extract on intestinal mucosal barrier may be im-
plemented through the mechanism.
Endotoxin was released by gram-negative bacilli and
Table 2 Comparison of gastrointestinal function in two groups (cases)
Group
Control
Treatment
Z, P value
Before treatment
0/1/2/3（score）
3/6 /11 /12
4/ 6/10 /12
Z=0.184, P=0.854
0/1/2/3（score）
4/6/10/10
5/7/8/9
Z=0.489, P=0.625
1 days after treatment
0/1/2/3（score）
3/5/9/10
6/9/9/4
Z=2.080, P=0.038
3 days after
treatment
0/1/2/3（score）
5/5/7/8
10/9/5/3
Z=2.169, P=0.030
7 days after treatment
Figure 2 Comparison of APACHE II in two groups
APACHE II: acute physiology and chronic health evaluation
II. Patients in control group received conventional treat-
ment; The extract from periplanetaamericana plus conven-
tional medications for sepsis was administered to the treat-
ment group.
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Figure 1 Comparison of endotoxin in two groups
Patients in control group received conventional treatment;
The extract from periplanetaamericana plus conventional
medications for sepsis was administered to the treatment
group.
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Notes: Patients in control group received conventional treatment; The extract from periplanetaamericana plus conventional medications
for sepsis was administered to the treatment group.
I control group
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LPS wasits main component. Monitoring endotoxin
has practical significance on assessing intestinal muco-
sal barrier injurycaused bysepsis. APACHE II score has
been widely used to predict prognosis and mortality, es-
pecially in ICU.13,14 After 3 and 7 days treatment with
periplaneta americana extract, endotoxin level and
APACHE II score, gastrointestinal function score were
better improved in treatment group than in control
group. The findings of our study suggested that peripla-
neta americana extract had a protective effect on the in-
testinal mucosal barrier and could improve the condi-
tion and prognosis in patients with sepsis.
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